Cited by

• A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.

  Li Q, Xin W, Gao S, Kang L, Wang J. Li Q, et al. Hum Vaccin Immunother. 2013 Nov;9(11):2386-92. doi: 10.4161/hv.25649. Epub 2013 Jul 8. Hum Vaccin Immunother. 2013. PMID: 23835363 Free PMC article.
• Clostridial enteric diseases of domestic animals.

  Songer JG. Songer JG. Clin Microbiol Rev. 1996 Apr;9(2):216-34. doi: 10.1128/CMR.9.2.216. Clin Microbiol Rev. 1996. PMID: 8964036 Free PMC article. Review. No abstract available.
• Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.

  McClain MS, Cover TL. McClain MS, et al. Infect Immun. 2007 Apr;75(4):1785-93. doi: 10.1128/IAI.01643-06. Epub 2007 Jan 29. Infect Immun. 2007. PMID: 17261609 Free PMC article.
• Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia.

  Bokori-Brown M, Hall CA, Vance C, Fernandes da Costa SP, Savva CG, Naylor CE, Cole AR, Basak AK, Moss DS, Titball RW. Bokori-Brown M, et al. Vaccine. 2014 May 13;32(23):2682-7. doi: 10.1016/j.vaccine.2014.03.079. Epub 2014 Apr 5. Vaccine. 2014. PMID: 24709588 Free PMC article.
• Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex.

  Petit L, Gibert M, Gillet D, Laurent-Winter C, Boquet P, Popoff MR. Petit L, et al. J Bacteriol. 1997 Oct;179(20):6480-7. doi: 10.1128/jb.179.20.6480-6487.1997. J Bacteriol. 1997. PMID: 9335299 Free PMC article.